FDA Clears Abilify Generics Despite Otsuka Objections
In the face of objections from Otsuka Pharmaceutical Co. Ltd., the U.S. Food and Drug Administration approved the first generic versions of the antipsychotic drug Abilify on Tuesday, despite Otsuka still...To view the full article, register now.
Already a subscriber? Click here to view full article